Essence Group Holdings Funding, Investors & Competitors

Essence Group Holdings has raised $337M across 2 funding rounds, most recently a $266M undisclosed-stage round in July 2018.

Last Essence Group Holdings funding round

$266M

Undisclosed stage · Jul 2018

Cumulative funding Essence Group Holdings raised

$337M

across 2 funding rounds

Key investors in Essence Group Holdings

  • Kleiner Perkins
  • The Blue Venture Fund
  • Sandbox Industries
  • Camden Partners
  • Cerner

Essence Group Holdings Overview

About Essence Group Holdings

Essence Group Holdings is a Maryland Heights, Missouri-headquartered holding company providing health insurance and SaaS solutions. Incorporated in 2007, it operates subsidiaries offering Medicare Advantage plans and electronic health record software to providers in the Midwest. The group serves 50,000 policyholders and integrates claims processing with telehealth platforms.


Founded

2007

HQ

United StatesSaint Louis, MO

Website

eghc.com

Status

Privately held

Customer focus

B2C & B2B

Revenue model

Product sales, Subscription

Essence Group Holdings Funding History

Essence Group Holdings has raised a total of $337M across 2 funding rounds.

Essence Group Holdings' first fundraising round was a $71M undisclosed-stage round in May 2014. The most recent completed round was a $266M undisclosed-stage round in July 2018.

Essence Group Holdings funding rounds

Essence Group Holdings funding rounds
DateStageInvestorsRaisedDeal Summary
Jul 2018Undisclosed stageCerner (lead)$266MOn July 27, 2018, Cerner Corporation acquired a minority interest in Essence Group Holdings Corporation for $266 million as part of a 10-year strategic partnership. Essence Group is a US-based healthcare services provider and the parent company of Lumeris, a population health management platform that helps healthcare systems and managed services organizations manage value-based care arrangements. Essence also owns Essence Healthcare, a Medicare Advantage health plan operating in Missouri and Illinois with approximately 60,000-65,000 beneficiaries. As part of the partnership, the two companies jointly developed Maestro Advantage, an EHR-agnostic technology platform designed to streamline value-based care delivery, including claims processing, reimbursement cycles, and data sharing for Medicare Advantage and provider-sponsored health plans. Lumeris adopted Cerner's HealtheIntent population health management platform to strengthen the integrated offering. Initial deployments of Maestro Advantage were expected by the end of 2018, with broader market rollout planned for 2019. Essence Group had previously raised approximately $185 million in funding prior to Cerner's investment, including a $70 million round in 2011 led by BlueCross BlueShield Venture Partners, and a $71 million round in 2014 featuring investors including Kleiner Perkins Caufield & Byers, Camden Partners, and Sandbox Industries. The strategic investment underscored Cerner's focus on population health management as the healthcare industry shifted toward value-based payment models, with Medicare Advantage enrollment reaching approximately 21 million beneficiaries in 2018.
May 2014Undisclosed stageThe Blue Venture Fund; Kleiner Perkins; Camden Partners; Sandbox Industries$71MEssence Group Holdings Corp., the parent company of Lumeris, is a St. Louis-based provider of population health management services, offering technology and services to health systems, health plans, and provider organizations to transition from fee-for-service to value-based care amid Affordable Care Act changes. Lumeris focuses on distributed patient care responsibilities and payment models, positioning the company to capitalize on regulatory-driven demand for population health management solutions. In July 2014, it raised $71 million from investors including Camden Partners, Kleiner Perkins Caufield & Byers, Sandbox Industries, and BlueCross BlueShield Venture Partners (The Blue Venture Fund), bringing total funding to approximately $141 million. The funds were allocated to expand Lumeris operations from eight to twenty markets by the end of 2015, aiming to partner with organizations covering more than 50 million lives. Essence Group Holdings had approximately $500 million in revenue in 2013, reflecting strong traction in the healthcare services sector as the industry shifted toward accountability and shared responsibility for better outcomes at lower costs. The round supported rapid expansion in the Midwest healthcare startup ecosystem, where investments reached $4.3 billion in 2014, highlighting Essence's role among notable Missouri-based players.

Who has invested in Essence Group Holdings?

5 investors have backed Essence Group Holdings across its funding rounds, including Kleiner Perkins, The Blue Venture Fund, Sandbox Industries, Camden Partners and Cerner.

Lead investors include Cerner.


Essence Group Holdings Investors

Investors in Essence Group Holdings by funding rounds participated
InvestorHQRoundsRoleFirst check
The Blue Venture FundUnited StatesChicago, IL1ParticipantMay 2014
Kleiner PerkinsUnited StatesSan Francisco, CA1ParticipantMay 2014
CernerUnited StatesKansas City, MO1LeadJul 2018

This data is available for Pro users. Sign up to see all 5 Essence Group Holdings investors.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

Essence Group Holdings Competitors

Essence Group Holdings competitors include listed companies like S&P Global, Moody's, Constellation Software and HiThink, and private ones like Ant Group and OneConnect.

Public and private companies comparable to Essence Group Holdings
CompanyHQStatusRevenueEBITDAValuationRevenue Multiple
S&P GlobalUnited StatesUnited StatesPublicly listed$15B$7.7B$119B9.1x
Moody'sUnited StatesUnited StatesPublicly listed$7.7B$3.8B$80B10.6x
Ant GroupChinaHangzhouPrivate$25B-$79B3.2x
Constellation SoftwareCanadaCanadaPublicly listed$12B$2.5B$43B3.5x
HiThinkChinaChinaPublicly listed$899M$530M$23B18.9x
OneConnectChinaShanghaiPrivate--$7.4B-

Essence Group Holdings Public Comps

Essence Group Holdings is still privately-owned, but its public comps include Berkshire Hathaway, Allianz, China Life, Ping An Insurance, Chubb, Progressive, S&P Global, Zurich Insurance Group, AXA and AIA Group.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Berkshire Hathaway$411B$101B2.9x3.0x11.7x-
Allianz$158B$20B1.3x0.9x10.2x10.0x
China Life$90B$28B1.8x1.7x5.8x6.0x
Ping An Insurance$138B$13B7.3x6.3x77.0x-
Chubb$60B$14B2.7x2.7x11.2x11.8x
Progressive$88B$15B1.5x1.5x9.0x8.8x
S&P Global$15B$7.7B8.9x9.1x17.6x17.3x
Zurich Insurance Group$89B$11B1.4x1.8x10.6x16.0x

This data is available for Pro users. Sign up to see all Essence Group Holdings competitors and their valuation data.

Start Free Trial

Common questions about Essence Group Holdings

When was Essence Group Holdings founded?Essence Group Holdings was founded in 2007.
Where is Essence Group Holdings headquartered?Essence Group Holdings is headquartered in Saint Louis, MO, United States.
Is Essence Group Holdings publicly listed?No, Essence Group Holdings is a private, VC-backed company.
How much funding has Essence Group Holdings raised?Essence Group Holdings has raised $337M across 2 funding rounds.
What was Essence Group Holdings' last funding round?Essence Group Holdings' last funding round was a $266M undisclosed-stage round in July 2018, led by Cerner.
Who are Essence Group Holdings' investors?Essence Group Holdings' investors include The Blue Venture Fund, Kleiner Perkins, Cerner, Camden Partners and Sandbox Industries.
Which companies are comparable to Essence Group Holdings?Companies comparable to Essence Group Holdings include S&P Global, Moody's, Ant Group, Constellation Software, HiThink and OneConnect.

See companies similar to Essence Group Holdings

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial